News & Media

Year: 2020

  On Thursday, May 28th, 2020, Lucerna will be giving a virtual talk to present the latest advances in its high-throughput RNA splicing drug discovery platform at the…

    Lucerna is announcing the launch of a new R&D program to develop a new high-throughput screening (HTS) platform to enable the rapid discovery of drugs that…

  Today, Lucerna announced the launch of the newest member in its fluorophore product line, DFHBI-BI or BI. A derivative of DFHBI, BI is the first photostable green…

    Lucerna has received a 1 year $225K SBIR Phase I grant from the National Institute of Allergy and Infectious Diseases to develop new high-throughput screening (HTS)…

    Lucerna has received a 2 year $1.5M SBIR Phase II contract from the National Cancer Institute to develop new R&D tools to enable scientists to better…

  Lucerna will be presenting at SLAS 2020 International Conference & Exhibition: January 25-29, 2020 San Diego, CA Booth # 2029M   Innovation AveNEW Ignite Award Presentation: Monday,…